Skip to main content
Fig. 3 | Pediatric Rheumatology

Fig. 3

From: Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study

Fig. 3

The association between IFX dose intensity and serum trough concentrations based on diagnosis. Dose intensity was determined as the average weight adjusted dose of IFX (i.e. mg/kg) per day, based on the timing between the last dose of IFX and the time at which the serum trough IFX concentrations were measured. a The association of IFX dose intensity and serum trough concentrations of IFX were evaluated by Spearman’s correlation analysis. The Spearman’s correlation coefficient (ρ) and associated p-value are provided. b Dose intensity stratified based on patient diagnosis is presented as a box and whisker plot and evaluated by unpaired analysis using the Wilcoxon rank-sum test and the resulting p-values are provided

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096